Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 81 - 90 of 144 results

First page
Previous page
Next page
Next page

LIQUID PETROLEUM

6ZAE7X688J

Status:

Possibly Marketed Outside US

Source:

21 CFR 347

(2018)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72896ba2-975f-50ff-e053-2991aa0a6af8

First approved in 2002

Source:

21 CFR 348

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f07da88-b008-5b3f-e053-2995a90ac7d4

Class:

STRUCTURALLY DIVERSE

GRAPE SEED OIL

930MLC8XGG

Status:

Possibly Marketed Outside US

Source:

CLBiO Cleansing Pack by CLBiO Co., LTD.

Source URL:

https://www.drugbank.ca/drugs/DB14323

First approved in 2002

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6f428cc-3d6f-43a4-a893-0453ec1f4c59

Class:

STRUCTURALLY DIVERSE

BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN

1O0600285A

Status:

Possibly Marketed Outside US

Source:

BLA103666

(2002)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

First approved in 2002

Source:

BLA103666

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

Class:

STRUCTURALLY DIVERSE

MIMOSA TENUIFLORA BARK

515MQE449I

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2006)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c209451-79c6-4bf3-a47b-c70bf0142375

First approved in 2002

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6f428cc-3d6f-43a4-a893-0453ec1f4c59

Class:

STRUCTURALLY DIVERSE

SPARGANIUM STOLONIFERUM ROOT

66ZQ85S65H

Status:

Possibly Marketed Outside US

Source:

21 CFR 348

(2002)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

First approved in 2002

Source:

21 CFR 348

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

Class:

STRUCTURALLY DIVERSE

AHNFELTIOPSIS CONCINNA

SMF2K46G8D

Status:

Possibly Marketed Outside US

Source:

M006

(2010)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5f20a88-09a7-4176-b831-14f1c1acaf4b

First approved in 2002

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=172ce1b6-4f93-4f2e-95f7-7315a5f2b6fd

Class:

STRUCTURALLY DIVERSE

BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)

F4TN0IPY37

Status:

Possibly Marketed Outside US

Source:

BLA103666

(2002)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

First approved in 2002

Source:

BLA103666

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06f34d0f-4e72-41d3-967f-8abf3f2005c1

Class:

STRUCTURALLY DIVERSE

ENTADA PHASEOLOIDES WHOLE

676S281WTB

Status:

Possibly Marketed Outside US

Source:

21 CFR 348

(2002)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

First approved in 2002

Source:

21 CFR 348

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

Class:

STRUCTURALLY DIVERSE

KUKUI NUT OIL

TP11QR7B8R

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2009)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ff3e10d-ae15-4132-a6a5-7c55db13b298

First approved in 2002

Source:

21 CFR 333D

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb365020-ac88-471b-812c-2ac2d79dcf53

Class:

STRUCTURALLY DIVERSE

Paratinospora sagittata root tuber

U65RN3L8Q5

Status:

Possibly Marketed Outside US

Source:

21 CFR 348

(2002)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

First approved in 2002

Source:

21 CFR 348

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36a9d533-1d00-4640-a764-c6d507a0b31c

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

LIQUID PETROLEUM

Structurally Diverse

Structurally Diverse

BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN

Structurally Diverse

MIMOSA TENUIFLORA BARK

Structurally Diverse

SPARGANIUM STOLONIFERUM ROOT

Structurally Diverse

AHNFELTIOPSIS CONCINNA

Structurally Diverse

BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)

Structurally Diverse

ENTADA PHASEOLOIDES WHOLE

Structurally Diverse

Structurally Diverse

Paratinospora sagittata root tuber

Showing 81 - 90 of 144 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1